The discovery and structure–activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase

2010 ◽  
Vol 20 (9) ◽  
pp. 2968-2973 ◽  
Author(s):  
Matthew G. LaPorte ◽  
Tandy L. Draper ◽  
Lori E. Miller ◽  
Charles W. Blackledge ◽  
Lara K. Leister ◽  
...  
2011 ◽  
Vol 21 (11) ◽  
pp. 3227-3231 ◽  
Author(s):  
Randy W. Jackson ◽  
Matthew G. LaPorte ◽  
Torsten Herbertz ◽  
Tandy L. Draper ◽  
Janet A. Gaboury ◽  
...  

2012 ◽  
Vol 22 (6) ◽  
pp. 2212-2215 ◽  
Author(s):  
A. Chris Krueger ◽  
Darold L. Madigan ◽  
David W. Beno ◽  
David A. Betebenner ◽  
Robert Carrick ◽  
...  

2013 ◽  
Vol 91 (1) ◽  
pp. 66-81 ◽  
Author(s):  
Pierre L. Beaulieu ◽  
René Coulombe ◽  
James Gillard ◽  
Christian Brochu ◽  
Jianmin Duan ◽  
...  

Acylsulfonamide and acylsulfamide as surrogates for the carboxylic acid function of N-acetamide-indole-6-carboxylic acids were evaluated as allosteric inhibitors of hepatitis C virus (HCV) NS5B polymerase. Several analogs displayed excellent antiviral potency against both 1a and 1b HCV genotypes in cell-based subgenomic replicon assays. Structure–activity relationships (SAR) are discussed in the context of the crystal structure of an inhibitor − NS5B polymerase complex. Absorption, distribution, metabolism, and excretion pharmacokinetic (ADME-PK) properties of this class of inhibitors are also described.


2015 ◽  
Vol 19 (4) ◽  
pp. 955-964 ◽  
Author(s):  
Apilak Worachartcheewan ◽  
Virapong Prachayasittikul ◽  
Alla P. Toropova ◽  
Andrey A. Toropov ◽  
Chanin Nantasenamat

Sign in / Sign up

Export Citation Format

Share Document